1. Home
  2. MXE vs ICCC Comparison

MXE vs ICCC Comparison

Compare MXE & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mexico Equity and Income Fund Inc. (The)

MXE

Mexico Equity and Income Fund Inc. (The)

N/A

Current Price

$13.11

Market Cap

54.4M

Sector

Finance

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$6.54

Market Cap

55.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MXE
ICCC
Founded
1990
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.4M
55.5M
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
MXE
ICCC
Price
$13.11
$6.54
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.3K
12.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.66%
N/A
EPS Growth
N/A
65.33
EPS
N/A
0.20
Revenue
N/A
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$32.15
Revenue Growth
N/A
51.64
52 Week Low
$8.26
$4.32
52 Week High
$14.30
$7.60

Technical Indicators

Market Signals
Indicator
MXE
ICCC
Relative Strength Index (RSI) 44.36 53.29
Support Level $13.07 $6.13
Resistance Level $14.30 $6.87
Average True Range (ATR) 0.30 0.24
MACD -0.17 -0.01
Stochastic Oscillator 45.41 68.57

Price Performance

Historical Comparison
MXE
ICCC

About MXE Mexico Equity and Income Fund Inc. (The)

Mexico Equity and Income Fund Inc. is a closed-end, non-diversified management investment company that aims for long-term capital appreciation and current income. It prominently invests in equity, convertible securities, and debt issued by Mexican companies, operating across various sectors. The fund benchmarks its performance against the Mexbol and MSCI Mexico Index. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: